Yasumasa Shirouzu

Summary

Country: Japan

Publications

  1. ncbi Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: the Kyoto experience
    Yasumasa Shirouzu
    Departments of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 12:1224-32. 2006
  2. ncbi Development of pulmonary hypertension in 5 patients after pediatric living-donor liver transplantation: de novo or secondary?
    Yasumasa Shirouzu
    Department of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 12:870-5. 2006
  3. ncbi Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University
    Daisuke Morioka
    Organ Transplant Unit, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 11:1332-42. 2005
  4. ncbi Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat
    Yasumasa Shirouzu
    Department of Surgery, Kurume University Faculty of Medicine, 67 Asahimachi, Kurume, Fukuoka, Japan
    Surg Today 34:341-8. 2004
  5. ncbi The fungal DNA examination is useful as a sensitive parameter for the initiation and the quit of antifungal therapy in immunocompromised pediatric patients after surgery
    Shigeki Hikida
    Departments of Pediatric Surgery, Kurume University School of Medicine, Kurume 830 0011, Japan
    Kurume Med J 51:125-31. 2004

Detail Information

Publications5

  1. ncbi Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: the Kyoto experience
    Yasumasa Shirouzu
    Departments of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 12:1224-32. 2006
    ..04). In conclusion, our surgical technique for smaller-size recipients resulted in an acceptable rate of vascular complications. Overcoming early posttransplantation complications will further improve outcomes in infantile LDLT...
  2. ncbi Development of pulmonary hypertension in 5 patients after pediatric living-donor liver transplantation: de novo or secondary?
    Yasumasa Shirouzu
    Department of Transplant Surgery, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 12:870-5. 2006
    ..Periodic echocardiography is essential for early detection and treatment of PH especially in the recipients with portal hypertension not only preoperatively but also postoperatively...
  3. ncbi Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University
    Daisuke Morioka
    Organ Transplant Unit, Kyoto University Hospital, Kyoto, Japan
    Liver Transpl 11:1332-42. 2005
    ..In conclusion, LT should be considered to be the definitive treatment for UCDs at this stage, although some issues remain unresolved...
  4. ncbi Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat
    Yasumasa Shirouzu
    Department of Surgery, Kurume University Faculty of Medicine, 67 Asahimachi, Kurume, Fukuoka, Japan
    Surg Today 34:341-8. 2004
    ..05). CONCLUSIONS: The Th2 deviation induced with intraportal alloantigen administration immediately after engraftment was thus observed to produce a synergistic effect with immunosuppressant treatment to suppress acute rejection...
  5. ncbi The fungal DNA examination is useful as a sensitive parameter for the initiation and the quit of antifungal therapy in immunocompromised pediatric patients after surgery
    Shigeki Hikida
    Departments of Pediatric Surgery, Kurume University School of Medicine, Kurume 830 0011, Japan
    Kurume Med J 51:125-31. 2004
    ..We conclude that the fungal DNA examination could be a sensitive parameter not only to start but to quit antifungal medication in pediatric patients with mycosis...